Cetera Investment Advisers Boosts Holdings in SPDR S&P Biotech ETF $XBI

Cetera Investment Advisers grew its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.2% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 157,722 shares of the exchange traded fund’s stock after buying an additional 3,392 shares during the quarter. Cetera Investment Advisers owned 0.29% of SPDR S&P Biotech ETF worth $13,080,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in XBI. DHJJ Financial Advisors Ltd. acquired a new stake in SPDR S&P Biotech ETF in the second quarter valued at about $25,000. Garrison Bradford & Associates Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $39,000. Quaker Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 101.2% in the 2nd quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock valued at $52,000 after buying an additional 53,536 shares during the period. Avalon Trust Co purchased a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $57,000. Finally, Curio Wealth LLC boosted its stake in shares of SPDR S&P Biotech ETF by 74,700.0% in the second quarter. Curio Wealth LLC now owns 748 shares of the exchange traded fund’s stock valued at $62,000 after buying an additional 747 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $114.50 on Thursday. The company has a market cap of $6.95 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $116.18. The business has a fifty day moving average of $105.41 and a two-hundred day moving average of $92.21.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.